Contact
Please use this form to send email to PR contact of this press release:
Chi-Med Initiates FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer
TO:
Please use this form to send email to PR contact of this press release:
Chi-Med Initiates FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer
TO: